J Li, H Liu, S Takagi, K Nitta, M Kitada,
SP Srivastava… - JCI insight, 2020 - ncbi.nlm.nih.gov
Abstract Sodium glucose cotransporter 2 (SGLT2) inhibitors are beneficial in halting diabetic
kidney disease; however, the complete mechanisms have not yet been elucidated. The …